Dystonia Image-based Programming of Stimulation: A Prospective, Randomized, Double-blind Crossover Trial
DIPS
1 other identifier
interventional
80
1 country
1
Brief Summary
The primary objective of this exploratory study is to prospectively evaluate the feasibility of image-guided programming of pallidal deep brain stimulation (DBS) for dystonia. The dystonias are a heterogeneous group of movement disorders that share the core clinical feature of abnormal involuntary muscle contractions in common. Pallidal DBS is an established therapy for severe cases with an average improvement in dystonia severity of 50-60%. However, outcomes are variable and difficult to predict, and clinical trials report up to 25% of Nonresponders. Variability in electrode placement and inappropriate stimulation settings may account for much of this variability in outcome. In addition, improvement in dystonia is delayed, often days to weeks after a change in DBS therapy, complicating programming. Our group recently developed a computer model to predict optimal individualized stimulation settings in patients based on the outcome of a large cohort of of chronically treated patients. In-silico testing showed a 16.3% better mean group improvement with computer-assisted programming compared with physician-assisted programming and a dramatic reduction in non-responders (from 25% to 5%). In this prospective study, the computer model will be compared in a randomized, controlled, and double blinded setting against best clinical DBS programming. The primary outcome will be a responder analysis in which dystonia severity will be compared between conventional clinical and model-based programming will be compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2021
CompletedFirst Posted
Study publicly available on registry
October 27, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 28, 2025
January 1, 2025
3.8 years
October 1, 2021
January 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
successful treatment with model predicted settings
The primary efficacy endpoint is based on the blinded physician rating of dystonia severity reflected by Clinical Dystonia Rating Scales (BFMDRS or TWSTRS). The raters will be internationally recognized leading experts in the field of movement disorders that are not part of the study team or otherwise related to our center. For both interventions (best clinical settings and model predicted settings) we will calculate the symptom severity score after 4 weeks of continuous stimulation, expressed in percent of the pre-operative score. The primary endpoint is defined as "successful treatment with model predicted settings" (yes or no). The value is "yes" if the motor symptoms with model predicted settings are equal or better (tolerance 5%) to clinical settings.
8 week follow-up
Secondary Outcomes (4)
quality of life SF-36 (Short Form-36)
4 week and 8 week follow-up
quality of life CDQ24
4 week and 8 week follow-up
calculated energy consumption
Baseline visit
time for programming
Baseline visit
Study Arms (2)
Computer
EXPERIMENTALProgramming based on computer-guided assessment
CLINICAL
ACTIVE COMPARATORProgramming based on clinically-guided assessment
Interventions
Eligibility Criteria
You may qualify if:
- Chronic deep brain stimulation (\> 1 year) in the internal globus pallidus in patients with isolated dystonia.
- Deep brain stimulation settings and dystonia medication stable for \> 3 months.
- Understanding about and consent to the study and signed informed consent form.
You may not qualify if:
- Relevant comorbidities that might interfere with study endpoints (esp. palliative disease and severe neurologic or psychiatric comorbidities).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Neurology, University Hospital Würzburg
Würzburg, Bavaria, 97080, Germany
Related Publications (1)
Lange F, Roothans J, Wichmann T, Gelbrich G, Roser C, Volkmann J, Reich M. DIPS (Dystonia Image-based Programming of Stimulation: a prospective, randomized, double-blind crossover trial). Neurol Res Pract. 2021 Dec 20;3(1):65. doi: 10.1186/s42466-021-00165-6.
PMID: 34924027DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Reich
Department of Neurology - University Hosiptal Würzburg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2021
First Posted
October 27, 2021
Study Start
November 1, 2021
Primary Completion
September 1, 2025
Study Completion
December 1, 2025
Last Updated
January 28, 2025
Record last verified: 2025-01